Abstract

Applying Quality of Design Concepts to Pharmacy Compounding

Author(s): Timko Robert J

Issue: Nov/Dec 2015 - Volume 19, Number 6

Page(s): 453-463

Download in electronic PDF format for $75
  • Applying Quality of Design Concepts to Pharmacy Compounding Page 1
  • Applying Quality of Design Concepts to Pharmacy Compounding Page 2
  • Applying Quality of Design Concepts to Pharmacy Compounding Page 3
  • Applying Quality of Design Concepts to Pharmacy Compounding Page 4
  • Applying Quality of Design Concepts to Pharmacy Compounding Page 5
  • Applying Quality of Design Concepts to Pharmacy Compounding Page 6
  • Applying Quality of Design Concepts to Pharmacy Compounding Page 7
  • Applying Quality of Design Concepts to Pharmacy Compounding Page 8
  • Applying Quality of Design Concepts to Pharmacy Compounding Page 9
  • Applying Quality of Design Concepts to Pharmacy Compounding Page 10
  • Applying Quality of Design Concepts to Pharmacy Compounding Page 11

Note: Electronic version includes supplemental material.

Abstract

Compounding of medications is an important part of the practice of the pharmacy profession. Because compounded medications do not have U.S. Food and Drug Administration approval, a pharmacist has the responsibility to ensure that compounded medications are of suitable quality, safety, and efficacy. The Federal Government and numerous states have updated their laws and regulations regarding pharmacy compounding as a result of recent quality issues. Compounding pharmacists are expected to follow Current Good Compounding Practices in their compounding practices in much the same way pharmaceutical manufacturers are required to follow Current Good Manufacturing Procedures as detailed in the United States Code of Federal Regulations. Application of Quality by Design concepts to the preparation process for a compounded medication can help in understanding the potential pitfalls and the means to mitigate their impact. The goal is to build quality into the compounding process to ensure that the resultant compounded prescription meets the human or animal patients’ requirements.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2015
Pg. 453-463
Author(s): Timko Robert J
Mar/Apr 2021
Pg. 115-124
Author(s): Kelley Brian
Mar/Apr 2012
Pg. 146-150
Author(s): Allen Loyd V Jr
Sep/Oct 2018
Pg. 401-404
Author(s): Martin Matt
Sep/Oct 2009
Pg. 412-418
Author(s): Zolner William J
May/Jun 2015
Pg. 215-221
Author(s): Akers Michael J
Jul/Aug 2020
Pg. 322-326
May/Jun 2011
Pg. 224-232
Mar/Apr 2020
Pg. 92
Author(s): Allen Loyd V Jr
Sep/Oct 2007
Pg. 400-403
Author(s): Kupiec Thomas C
Jul/Aug 2016
Pg. 351
View Sample
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 180
Author(s): Allen Loyd V Jr
Mar/Apr 2015
Pg. 121-124
Author(s): Akers Michael J
Sep/Oct 2007
Pg. 357-362
Author(s): DeVeau Ian
Sep/Oct 2008
Pg. 410-413
Author(s): Kirk Loren Madden
Jul/Aug 2001
Pg. 265-267
Mar/Apr 2017
Pg. 95-102
Author(s): Yoch Doug
May/Jun 2022
Pg. 182-186
Author(s): Standridge Rob
Jul/Aug 2020
Pg. 299-303
Author(s): Taylor Andrew
May/Jun 2023
Pg. 211-217
Author(s): Hawkins Jessica